A detailed history of Visionary Wealth Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Visionary Wealth Advisors holds 2,357 shares of NVO stock, worth $254,579. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,357
Previous 3,563 33.85%
Holding current value
$254,579
Previous $508,000 44.88%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $143,598 - $175,376
-1,206 Reduced 33.85%
2,357 $280,000
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $41,966 - $50,243
342 Added 10.62%
3,563 $508,000
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $64,022 - $85,221
627 Added 24.17%
3,221 $413,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $26,334 - $31,635
300 Added 13.08%
2,594 $268,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $208,616 - $457,744
2,294 New
2,294 $208,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Visionary Wealth Advisors Portfolio

Follow Visionary Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.